Construct | Sub-construct | Item | Domains |
---|---|---|---|
Change commitment | Needed | I believe that [COUNTRY] needs to interrupt STH transmission. | Policy environment |
I have observed that my co-workers generally believe that [COUNTRY] needs to interrupt STH transmission. | Policy environment | ||
Motivated | I am supportive of implementing community-wide MDA for STH. | Policy environment | |
I have observed that my co-workers are generally supportive of implementing community-wide MDA for STH. | Policy environment | ||
Ministry of Education personnel that I work with on school or child interventions will likely support transitioning from school-based to community-wide deworming. | Leadership | ||
In my experience, community drug distributors are given sufficient financial and/or non-financial incentives for administering community-wide MDA. | Financial resources | ||
Outcome expectancy | I believe that community-wide MDA can interrupt STH transmission in [COUNTRY].* | Policy environment | |
I have observed that my co-workers generally believe that community-wide MDA can interrupt STH transmission in [COUNTRY]. | Policy environment | ||
Change efficacy | Task demand | In my experience, community drug distributor supervisors provide good guidance to distributors on how to deliver community-wide MDA. | Leadership |
[Stakeholder level] staff will need additional training to effectively deliver community-wide MDA for STH. | Human resources | ||
Additional supervisors are needed at [stakeholder level] to coordinate the delivery of community-wide MDA for STH. | Human resources | ||
In my experience, personnel at [stakeholder level] have demonstrated that they can deliver other community-wide MDA programmes (ex. lymphatic filariasis) with high coverage. | Technical capacity | ||
Resource availability | How often have you observed difficulties with having enough funding at the National level to support implementation of community-based programmes? | Financial resources | |
How often do you encounter difficulties with having enough funding at the district level to implement of community-based programmes? | Financial resources | ||
I am not worried about whether [COUNTRY] has sufficient future funding for community-wide MDA programmes. | Financial resources | ||
[COUNTRY] currently has the resources and tools needed to develop high-quality sensitization and education materials for community-wide MDA for STH. | Material resources | ||
In my experience, there is an effective programme in [COUNTRY] for training community drug distributors on how to deliver community-wide MDA. | Technical capacity | ||
I know of at least one community health programme that could be used to deliver community-wide MDA for STH.* | Community delivery-infrastructure | ||
Contextual factors | I have observed that there is a collaborative network of external stakeholders (NGOs or technical/financial partners) that would support community-wide MDA for STH in [COUNTRY]. | Policy environment | |
How often are community members in [COUNTRY] resistant to community-wide MDA campaigns? | Community-delivery infrastructure | ||
Capacity | Demonstrated capacity | In my experience, [COUNTRY’s] National NTD Master Plan is currently being implemented as intended. | Policy environment |
How often have you encountered difficulty moving money across [stakeholder level of the health system] for a community-based programme? | Financial resources | ||
How often have you observed delays in the arrival of drugs for MDA programmes due to supply chain problems? | Material capacity | ||
I have observed that it is challenging to recruit enough community drug distributors needed in [COUNTRY] to deliver community-wide MDA. | Human resources | ||
How often are treatment data incorrectly recorded during delivery of community-wide MDA programmes? | Technical capacity | ||
In my experience, community drug distributors have the skills to effectively deliver community-wide MDA for STH. | Community-delivery infrastructure | ||
Flexibility | Flexibility | It is challenging to present new ideas to my supervisor. | Leadership |
In my experience, when MOH leadership at the National level are presented with new ideas, research activities, or pilot projects, they are generally receptive to them. | Leadership | ||
How often do your supervisors generally feel comfortable receiving feedback and recommendations from you and your colleagues on how to improve the delivery of interventions? | Leadership | ||
How often do your subordinates generally feel comfortable providing feedback and recommendations on how to improve the delivery of interventions? | Leadership | ||
Organizational structure | Leadership structure | In my experience, the NTD programme leadership at the national level is effectively implementing community-wide MDA programmes in [COUNTRY]. | Leadership |
In my experience, the NTD programme leadership at the [STATE] level is effectively implementing NTD programmes in [COUNTRY]. | Leadership | ||
In my experience, the NTD programme leadership at the [DISTRICT]l level is effectively implementing NTD programmes in [COUNTRY]. | Leadership | ||
Political structure | In my experience, [COUNTRY] 's national policy for NTD control supports community-wide MDA. | Policy environment | |
I have observed that [COUNTRY]'s National NTD Master Plan provides sufficient guidance for delivering community-wide MDA programmes, such as lymphatic filariasis (LF). | Policy environment | ||
I have observed that deworming medicines are acquired centrally and re-distributed to local levels without too much difficulty. | Material resources |